PF-06817024

PF-06817024 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06817024, covering 2022-05-19 to 2022-05-19. Get the full timeline:

Most recent: Clinical Trial Update: Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis [Phase 1]

See pricing